Literature DB >> 14747210

Utility of casual postprandial glucose levels in type 2 diabetes management.

Imad M El-Kebbi1, David C Ziemer, Curtiss B Cook, Daniel L Gallina, Catherine S Barnes, Lawrence S Phillips.   

Abstract

OBJECTIVE: Because readily available glycemic indicators are needed to guide clinical decision-making for intensification of diabetes therapy, our goals were to define the relationship between casual postprandial plasma glucose (cPPG) levels and HbA(1c) in patients with type 2 diabetes and to determine the predictive characteristics of a convenient glucose cutoff. RESEARCH DESIGN AND METHODS: We examined the relationship between cPPG levels (1-4 h post meal) and HbA(1c) levels in 1,827 unique patients who had both determinations during a single office visit.
RESULTS: The population studied was predominantly African American and middle-aged, with average cPPG of 201 mg/dl and HbA(1c) of 8.4%. The prevalence of HbA(1c) > or = 7.0% was 67% and HbA(1c) >6.5% was 77%. Overall, cPPG and HbA(1c) were linearly correlated (r = 0.63, P < 0.001). The correlation between cPPG and HbA(1c) was strongest in patients treated with diet alone (n = 348, r = 0.75, P < 0.001) and weaker but still highly significant for patients treated with oral agents (n = 610, r = 0.64, P < 0.001) or insulin (n = 869, r = 0.56, P < 0.001). A cutoff cPPG >150 mg/dl predicted an HbA(1c) level > or = 7.0% in the whole group, with a sensitivity of 78%, a specificity of 62%, and an 80% positive predictive value. The same cPPG cutoff of 150 mg/dl predicted an HbA(1c) level >6.5%, with a sensitivity of 74%, a specificity of 66%, and an 88% positive predictive value.
CONCLUSIONS: When rapid-turnaround HbA(1c) determinations are not available, a single cPPG level >150 mg/dl may be used during a clinic visit to identify most inadequately controlled patients and allow timely intensification of therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747210     DOI: 10.2337/diacare.27.2.335

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  13 in total

Review 1.  Metabolic syndrome, aging and involvement of oxidative stress.

Authors:  Francesca Bonomini; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

Review 2.  Prandial hyperglycemia: is it important to track and treat?

Authors:  Markolf Hanefeld; Frank Schaper
Journal:  Curr Diab Rep       Date:  2005-10       Impact factor: 4.810

Review 3.  Upper gastrointestinal function and glycemic control in diabetes mellitus.

Authors:  Reawika Chaikomin; Christopher K Rayner; Karen-L Jones; Michael Horowitz
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

Review 4.  Is there a relationship between mean blood glucose and glycated hemoglobin?

Authors:  Konstantinos Makris; Loukia Spanou
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

5.  Diabetes management in urban African Americans: review of a public hospital experience.

Authors:  David C Ziemer; Imad M El-Kebbi; Guillermo E Umpierrez; Mary K Rhee; Lawrence S Phillips; Curtiss B Cook
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

Review 6.  Role of melatonin in metabolic regulation.

Authors:  Ahmet Korkmaz; Turgut Topal; Dun-Xian Tan; Russel J Reiter
Journal:  Rev Endocr Metab Disord       Date:  2009-12       Impact factor: 6.514

Review 7.  [Blood glucose control in type 2 diabetes. Basic requirements for reducing vascular complications].

Authors:  J Seissler
Journal:  Internist (Berl)       Date:  2007-07       Impact factor: 0.743

8.  Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study.

Authors:  Shinichi Umezawa; Akira Kubota; Hajime Maeda; Akira Kanamori; Kiyokazu Matoba; Yasuyuki Jin; Fuyuki Minagawa; Mitsuo Obana; Kotaro Iemitsu; Shogo Ito; Hikaru Amamiya; Mizuki Kaneshiro; Masahiko Takai; Hideaki Kaneshige; Kazuhiko Hoshino; Masashi Ishikawa; Nobuaki Minami; Tetsuro Takuma; Nobuo Sasai; Sachio Aoyagi; Takehiro Kawata; Atsuko Mokubo; Yukiko Miyairi; Hiroshi Takeda; Shin Honda; Hideo Machimura; Tetsuya Motomiya; Manabu Waseda; Yoshikazu Naka; Yasushi Tanaka; Yasuo Terauchi; Ikuro Matsuba
Journal:  BMC Endocr Disord       Date:  2015-07-03       Impact factor: 2.763

9.  Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes.

Authors:  Tongzhi Wu; Michelle J Bound; Beiyi R Zhao; Scott D Standfield; Max Bellon; Karen L Jones; Michael Horowitz; Christopher K Rayner
Journal:  Diabetes Care       Date:  2013-01-28       Impact factor: 19.112

Review 10.  Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia.

Authors:  E Wright; J L Scism-Bacon; L C Glass
Journal:  Int J Clin Pract       Date:  2006-03       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.